BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31412876)

  • 1. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children.
    Wang W; Zhou Y; Zhong L; Wang L; Tang X; Ma M; Li J; Song H
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):55. PubMed ID: 31412876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.
    Shiota M; Yang X; Kubokawa M; Morishima T; Tanaka K; Mikami M; Yoshida K; Kikuchi M; Izawa K; Nishikomori R; Okuno Y; Wang X; Sakaguchi H; Muramatsu H; Kojima S; Miyano S; Ogawa S; Takagi M; Hata D; Kanegane H
    J Clin Immunol; 2015 Jul; 35(5):454-8. PubMed ID: 25896945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD).
    Papa R; Rusmini M; Schena F; Traggiai E; Coccia MC; Caorsi R; Arrigo S; Pasetti F; Signa S; Barone P; Santamaria G; Spirito G; Sanges R; Vozzi D; Cavalli A; Gustincich S; Ravelli A; Gattorno M; Ceccherini I; Volpi S
    Clin Immunol; 2021 Oct; 231():108837. PubMed ID: 34455097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).
    Neven Q; Boulanger C; Bruwier A; de Ville de Goyet M; Meyts I; Moens L; Van Damme A; Brichard B
    J Clin Immunol; 2021 Jan; 41(1):51-58. PubMed ID: 33011939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial and Deep Cutaneous Involvement by RAS-Associated Autoimmunne Leukoproliferative Disease (RALD Cutis): A Histologic Mimicker of Histiocytoid Sweet Syndrome.
    Tran TAN; Grow WB; Chang CC
    Am J Dermatopathol; 2019 Aug; 41(8):606-610. PubMed ID: 31335417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation.
    Li G; Li Y; Liu H; Shi Y; Guan W; Zhang T; Yao W; Wu B; Xu H; Sun L
    Medicine (Baltimore); 2020 May; 99(20):e20232. PubMed ID: 32443356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ras-associated autoimmune leukoproliferative disorder: a report of 2 cases and literature review].
    He TY; Li CR; Xia Y; Liang FF; Luo Y; Yang J
    Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):853-857. PubMed ID: 29141318
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
    Kurita D; Shiba N; Ohya T; Murase A; Shimosato Y; Yoshitomi M; Hattori S; Sasaki K; Nishimura K; Tsujimoto SI; Takeuchi M; Tanoshima R; Kanegane H; Kitagawa N; Ito S
    J Clin Immunol; 2023 Nov; 43(8):1992-1996. PubMed ID: 37644277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous involvement in an 8-year-old boy with Ras-associated autoimmune leucoproliferative disorder (RALD).
    Giacaman A; Bauzá Alonso A; Salinas Sanz JA; Dapena Díaz JL; Ramos Asensio R; Ferrés Ramis L; Durán Pastor MA; Martín-Santiago A
    Clin Exp Dermatol; 2018 Dec; 43(8):913-916. PubMed ID: 29908030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing.
    Levy-Mendelovich S; Lev A; Rechavi E; Barel O; Golan H; Bielorai B; Neumann Y; Simon AJ; Somech R
    Clin Exp Immunol; 2017 Sep; 189(3):310-317. PubMed ID: 28500641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic splenomegaly in childhood and the spectrum of RAS-associated lymphoproliferative disease: a case report.
    Blanchard-Rohner G; Ragotte RJ; Junker AK; Sharma M; Del Bel KL; Lu HY; Erdle S; Chomyn A; Gill H; Tucker LB; Schreiber RA; Rozmus J; Biggs CM; Hildebrand KJ; Wu J; Stockler-Ipsiroglu S; Turvey SE
    BMC Pediatr; 2021 Jan; 21(1):45. PubMed ID: 33472608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus.
    Ragotte RJ; Dhanrajani A; Pleydell-Pearce J; Del Bel KL; Tarailo-Graovac M; van Karnebeek C; Terry J; Senger C; McKinnon ML; Seear M; Prendiville JS; Tucker LB; Houghton K; Cabral DA; Guzman J; Petty RE; Brown KL; Tekano J; Wu J; Morishita KA; Turvey SE
    Clin Immunol; 2017 Feb; 175():143-146. PubMed ID: 28043923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.
    Toyoda H; Deguchi T; Iwamoto S; Kihira K; Hori H; Komada Y; Hirayama M
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e516-e518. PubMed ID: 30080751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation.
    Law SM; Akizuki S; Morinobu A; Ohmura K
    Inflamm Regen; 2022 Apr; 42(1):10. PubMed ID: 35361277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.
    Calvo KR; Price S; Braylan RC; Oliveira JB; Lenardo M; Fleisher TA; Rao VK
    Blood; 2015 Apr; 125(18):2753-8. PubMed ID: 25691160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An atypical case of late-onset systemic lupus erythematosus with systemic lymphadenopathy and severe autoimmune thrombocytopenia/neutropenia mimicking malignant lymphoma.
    Tamaki K; Morishima S; Nakachi S; Kitamura S; Uchibori S; Tomori S; Hanashiro T; Shimabukuro N; Tedokon I; Morichika K; Nishi Y; Tomoyose T; Karube K; Fukushima T; Masuzaki H
    Int J Hematol; 2017 Apr; 105(4):526-531. PubMed ID: 27848183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
    Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
    BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome.
    Al-Mayouf SM; Alreefi HA; Alsinan TA; AlSalmi G; AlRowais A; Al-Herz W; Alazami AM; Alsonbul A; Al-Mousa H
    Mod Rheumatol; 2021 Nov; 31(6):1171-1178. PubMed ID: 33563058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.